ICE vs RNAZ · P/E 37, rev $7.28B vs $5.1M cap
Intercontinental Exchange Inc (ICE) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
RNAZ does not have a complete income-statement cache yet.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the ICE and RNAZ stock pages for the full models.
Not investment advice.